Comprehensive Scientific Analysis Links Chemical Glyphosate to Non-Hodgkin Lymphoma

An encompassing new scientific analysis of the chemical glyphosate has found that people with high levels of exposure to the herbicide have a 41% increased risk of developing non-Hodgkin lymphoma.

Glyphosate is the most commonly used base-agent in weedkilling products worldwide.

The analysis consists of finding by five US scientists.

These scientists’ findings directly contradict the Environmental Protection Agency’s (EPA) previously research, which has found glyphosate to be a non-carcinogenic agent.

The independence of the EPA’s research has been brought into question and is under review.

However, a 2015 study conducted by the International Agency for Research on Cancer (IARC) has classified glyphosate as a probable human carcinogen.

According to the analysis, the evidence “supports a compelling link” between exposure to glyphosate-based herbicides and increased risk for non-Hodgkin lymphoma.

New regulations limiting the use of glyphosate are currently being considered by regulators in numerous countries.

Domestically, there are more than 9,000 lawsuits filed against Monsanto – a company that produces glyphosate-based Roundup weed-killer – on behalf of individuals who were exposed to Roundup and developed non-Hodgkin lymphoma.

In August, a unanimous jury decision found in favor of the first plaintiff to go to trial in a Roundup lawsuit.

The second trial is scheduled to begin in late February.

Monsanto contends that the EPA’s findings were accurate and that other research linking glyphosate to non-Hodgkin lymphoma was conducted improperly and failed to consider the findings of similar studies.